QXT

Infliximab Test System

Product code
QXT
Device name
Infliximab Test System
Device class
Class 2
21 CFR
21 CFR 862.3115
Medical specialty
Clinical Toxicology
Marketing pathway
510(K)
510(k) clearances (last 3 years)
1
Summaries archived here
0 (direct download)
510(k) clearances (all years, FDA)
1 (all years; only the last 3 years are listed here)

FDA classification definition

An infliximab test system intended for the measurement of an infliximab as an aid in the management of patients with Crohn’s disease or ulcerative colitis.

Definition text from the FDA device classification database (U.S. federal government work, public domain).

510(k) clearances, last 3 years (1)

Last three years. Most recent: 2023-09-29.

NumberDecision dateApplicantDevice nameSummary
DEN2100562023-09-29Procisedx, Inc.Procise IFX
Official FDA classification page: QXT
Classification and pathway per current FDA publications. Data from openFDA (CC0).